USANA Health Sciences (NYSE:USNA) Updates FY 2025 Earnings Guidance

USANA Health Sciences (NYSE:USNA) updated its FY 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 2.350-3.000 for the period, compared to the consensus estimate of 2.870. The company issued revenue guidance of $920.0 million-$1.0 billion, compared to the consensus revenue estimate of $934.5 million.

Wall Street Analyst Weigh In

USNA has been the topic of several research analyst reports. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Sidoti downgraded USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a report on Tuesday, February 18th. Finally, DA Davidson reduced their price objective on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a research note on Thursday.

USANA Health Sciences Stock Performance

Shares of USNA stock traded down $4.64 during trading on Thursday, hitting $28.57. 554,986 shares of the company were exchanged, compared to its average volume of 163,121. The business’s 50-day simple moving average is $33.62 and its 200 day simple moving average is $36.61. USANA Health Sciences has a twelve month low of $27.71 and a twelve month high of $50.32. The firm has a market capitalization of $544.54 million, a price-to-earnings ratio of 10.10, a P/E/G ratio of 0.93 and a beta of 0.87.

USANA Health Sciences (NYSE:USNA) last issued its earnings results on Tuesday, February 25th. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The company had revenue of $213.61 million during the quarter, compared to analyst estimates of $208.82 million. On average, equities analysts forecast that USANA Health Sciences will post 2.45 earnings per share for the current fiscal year.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.